We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Emerson Q2 Earnings Top Estimates, Software and Control Sales Rise
Read MoreHide Full Article
Emerson Electric Co. (EMR - Free Report) reported second-quarter fiscal 2025 (ended March 31, 2025) adjusted earnings of $1.48 per share, which beat the Zacks Consensus Estimate of $1.42. The bottom line increased 9% year over year.
Emerson’s net sales of $4.43 billion beat the consensus estimate of $4.38 billion. The top line increased 1% year over year, driven by the solid performance of Software and Control segment. The company’s underlying sales were up 2% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
How EMR Business Segments Performed
Effective from the first quarter of fiscal 2023, the company started reporting under two segments, namely Intelligent Devices and Software & Control.
The Intelligent Devices segment’s net sales were $3.03 billion, down 1% year over year. Our estimate was $3.06 billion. The segment consists of four subgroups, namely Final Control, Measurement & Analytical, Discrete Automation and Safety & Productivity.
Final Control’s sales increased 2% year over year to $1.07 billion. Measurement & Analytical generated sales of $1 billion, down 1% year over year. Discrete Automation’s sales totaled $615 million, reflecting a decline of 3% on a year-over-year basis. Safety & Productivity’s sales decreased 7% year over year to $339 million.
The Software and Control Automation Solutions segment generated net sales of $1.42 billion, up 7% year over year. Our estimate was $1.34 billion. The segment consists of two subgroups, namely Control Systems & Software and Test & Measurement.
Control Systems & Software reported sales of $1.06 billion, reflecting an increase of 10% year over year. Test & Measurement sales were $359 million, declining 2% year over year.
Emerson Electric Co. Price, Consensus and EPS Surprise
The cost of sales decreased 1.5% year over year to $2.06 billion. The pretax earnings margin was 14.2% compared with 16.3% in the year-ago period. Adjusted EBITA margin was 25.8% compared with 24.5% in the year-earlier quarter. Selling, general and administrative expenses declined 1% year over year to $1.28 billion.
EMR’s Balance Sheet & Cash Flow
Exiting the fiscal second quarter, Emerson had cash and cash equivalents of $1.89 billion compared with $3.6 billion at the end of fiscal 2024 (ended September 2024). Long-term debt was $8.18 billion compared with $7.2 billion at the end of fiscal 2024.
In the same period, the company generated net cash of $1.02 billion from operating activities, up 12.1% year over year. Capital expenditure was $170 million, up from $159 million in the year-ago period. Emerson paid out dividends of $598 million and repurchased shares worth $1.12 billion in the same period.
Emerson’s Q3 Fiscal 2025 Outlook
For the third quarter of fiscal 2025 (ending June 2025), Emerson anticipates year-over-year net sales growth to be in the band of 4.5–5.5% and underlying sales growth to be in the range of 3.5-4.5%.
EMR anticipates adjusted earnings per share to be in the range of $1.48–$1.52.
EMR’s FY25 Outlook
Emerson currently anticipates net sales growth of approximately 4% from the year-earlier level compared with 1.5-3.5% expected earlier. Underlying sales are expected to rise approximately 4%.
EMR continues to project earnings per share to be in the range of $4.05-$4.20 compared with $4.42-$4.62 expected earlier. Adjusted earnings per share are estimated to be in the range of $5.90 - $6.05 compared with $5.85-$6.05 estimated earlier. The company expects operating cash flow to be in the band of $3.5-$3.6 billion. Free cash flow is estimated to be in the range of $3.1-$3.2 billion.
EMR’s Zacks Rank
The company currently carries a Zacks Rank #3 (Hold).
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the second quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the second quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Emerson Q2 Earnings Top Estimates, Software and Control Sales Rise
Emerson Electric Co. (EMR - Free Report) reported second-quarter fiscal 2025 (ended March 31, 2025) adjusted earnings of $1.48 per share, which beat the Zacks Consensus Estimate of $1.42. The bottom line increased 9% year over year.
Emerson’s net sales of $4.43 billion beat the consensus estimate of $4.38 billion. The top line increased 1% year over year, driven by the solid performance of Software and Control segment. The company’s underlying sales were up 2% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
How EMR Business Segments Performed
Effective from the first quarter of fiscal 2023, the company started reporting under two segments, namely Intelligent Devices and Software & Control.
The Intelligent Devices segment’s net sales were $3.03 billion, down 1% year over year. Our estimate was $3.06 billion. The segment consists of four subgroups, namely Final Control, Measurement & Analytical, Discrete Automation and Safety & Productivity.
Final Control’s sales increased 2% year over year to $1.07 billion. Measurement & Analytical generated sales of $1 billion, down 1% year over year. Discrete Automation’s sales totaled $615 million, reflecting a decline of 3% on a year-over-year basis. Safety & Productivity’s sales decreased 7% year over year to $339 million.
The Software and Control Automation Solutions segment generated net sales of $1.42 billion, up 7% year over year. Our estimate was $1.34 billion. The segment consists of two subgroups, namely Control Systems & Software and Test & Measurement.
Control Systems & Software reported sales of $1.06 billion, reflecting an increase of 10% year over year. Test & Measurement sales were $359 million, declining 2% year over year.
Emerson Electric Co. Price, Consensus and EPS Surprise
Emerson Electric Co. price-consensus-eps-surprise-chart | Emerson Electric Co. Quote
Emerson’s Margin Details
The cost of sales decreased 1.5% year over year to $2.06 billion. The pretax earnings margin was 14.2% compared with 16.3% in the year-ago period. Adjusted EBITA margin was 25.8% compared with 24.5% in the year-earlier quarter. Selling, general and administrative expenses declined 1% year over year to $1.28 billion.
EMR’s Balance Sheet & Cash Flow
Exiting the fiscal second quarter, Emerson had cash and cash equivalents of $1.89 billion compared with $3.6 billion at the end of fiscal 2024 (ended September 2024). Long-term debt was $8.18 billion compared with $7.2 billion at the end of fiscal 2024.
In the same period, the company generated net cash of $1.02 billion from operating activities, up 12.1% year over year. Capital expenditure was $170 million, up from $159 million in the year-ago period. Emerson paid out dividends of $598 million and repurchased shares worth $1.12 billion in the same period.
Emerson’s Q3 Fiscal 2025 Outlook
For the third quarter of fiscal 2025 (ending June 2025), Emerson anticipates year-over-year net sales growth to be in the band of 4.5–5.5% and underlying sales growth to be in the range of 3.5-4.5%.
EMR anticipates adjusted earnings per share to be in the range of $1.48–$1.52.
EMR’s FY25 Outlook
Emerson currently anticipates net sales growth of approximately 4% from the year-earlier level compared with 1.5-3.5% expected earlier. Underlying sales are expected to rise approximately 4%.
EMR continues to project earnings per share to be in the range of $4.05-$4.20 compared with $4.42-$4.62 expected earlier. Adjusted earnings per share are estimated to be in the range of $5.90 - $6.05 compared with $5.85-$6.05 estimated earlier. The company expects operating cash flow to be in the band of $3.5-$3.6 billion. Free cash flow is estimated to be in the range of $3.1-$3.2 billion.
EMR’s Zacks Rank
The company currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Companies
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the second quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the second quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.